Innovate UK
Tailor Bio Receives £650K UK Biomedical Grant to Develop Predictive Diagnostic for Ovarian Cancer
The startup will work with Illumina and the University of Cambridge to develop a test that identifies which ovarian cancer patients won't respond to doxorubicin chemotherapy.
DNAe, Imperial College London, U of Leicester to Develop NGS-Based Breast Cancer Monitoring Test
The project comes with an Innovate UK Knowledge Transfer Partnership award, which formalizes a collaboration between DNAe and Imperial College London.
Artelo Biosciences Joins UK Program to Further Develop FABP5 Inhibitor
The UK's Alderley Park Oncology Development Program will fund Artelo's ART26.12 program and explore the role of FABP5 expression in treatment response.
My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal Cancer Patients
Premium
The company, which uses fruit fly "avatars" to screen drugs, will be collaborating with London IVD Co-operative and Genomics England to test their technology in GI cancer patients.